NYSE:ALUR Allurion Technologies (ALUR) Stock Price, News & Analysis $0.86 -0.01 (-1.15%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.84▼$0.9050-Day Range$0.86▼$2.5952-Week Range$0.81▼$9.00Volume152,535 shsAverage Volume492,449 shsMarket Capitalization$41.22 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Allurion Technologies alerts: Email Address Allurion Technologies MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside481.7% Upside$5.00 Price TargetShort InterestHealthy1.55% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.65) to ($0.48) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.61 out of 5 starsMedical Sector491st out of 925 stocksSurgical & Medical Instruments Industry67th out of 98 stocks 3.5 Analyst's Opinion Consensus RatingAllurion Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageAllurion Technologies has only been the subject of 1 research reports in the past 90 days.Read more about Allurion Technologies' stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.55% of the float of Allurion Technologies has been sold short.Short Interest Ratio / Days to CoverAllurion Technologies has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Allurion Technologies has recently decreased by 36.47%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAllurion Technologies does not currently pay a dividend.Dividend GrowthAllurion Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ALUR. Previous Next 1.9 News and Social Media Coverage News SentimentAllurion Technologies has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Allurion Technologies this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for ALUR on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows3 people have added Allurion Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Allurion Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders20.00% of the stock of Allurion Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 21.39% of the stock of Allurion Technologies is held by institutions.Read more about Allurion Technologies' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Allurion Technologies are expected to grow in the coming year, from ($0.65) to ($0.48) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Allurion Technologies is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Allurion Technologies is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Allurion Technologies' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressElon Musk: “This Could be Massive…a Multi Trillion-Dollar Company.”Have you seen Elon Musk’s latest crazy prediction?Click here to see it because he believes this new venture… About Allurion Technologies Stock (NYSE:ALUR)Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Read More ALUR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ALUR Stock News HeadlinesJuly 20, 2024 | finance.yahoo.comALUR Aug 2024 0.500 put (ALUR240816P00000500)July 20, 2024 | finance.yahoo.comALUR Feb 2025 7.500 call (ALUR250221C00007500)July 28, 2024 | Porter & Company (Ad)Obama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.” June 26, 2024 | businesswire.comAllurion Announces Launch of Offering of Common Stock and WarrantsJune 20, 2024 | investorplace.comWhy Is Allurion (ALUR) Stock Up 140% Today?June 20, 2024 | businesswire.comAllurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight LossJune 5, 2024 | businesswire.comAllurion Announces the Appointment of Ojas A. Buch as Chief Operating OfficerMay 30, 2024 | businesswire.comAllurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1sJuly 28, 2024 | Porter & Company (Ad)Obama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.” May 29, 2024 | businesswire.comAllurion to Participate in Two Upcoming Investor Conferences in June 2024May 17, 2024 | finance.yahoo.comAllurion Technologies Inc. (ALUR)May 16, 2024 | insidermonkey.comAllurion Technologies Inc. (NYSE:ALUR) Q1 2024 Earnings Call TranscriptMay 15, 2024 | businesswire.comAllurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight LossMay 14, 2024 | msn.comAllurion Technologies GAAP EPS of $0.11, revenue of $9.4M beats by $0.4MMay 14, 2024 | investorplace.comALUR Stock Earnings: Allurion Technologies Beats EPS, Beats Revenue for Q1 2024May 14, 2024 | businesswire.comAllurion Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 4, 2024 | markets.businessinsider.comAllurion Technologies Inc Registered Shs hosts conference call for investorsMay 2, 2024 | businesswire.comAllurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance SurveySee More Headlines Receive ALUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Allurion Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today7/28/2024Next Earnings (Confirmed)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSE:ALUR Previous SymbolNYSE:ALUR CUSIPN/A CIK1964979 Webwww.allurion.com Phone508-647-4000FaxN/AEmployees501Year FoundedN/APrice Target and Rating Average Stock Price Target$5.00 High Stock Price Target$5.00 Low Stock Price Target$5.00 Potential Upside/Downside+481.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($3.79) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-80,610,000.00 Net Margins-117.30% Pretax Margin-116.67% Return on EquityN/A Return on Assets-85.06% Debt Debt-to-Equity RatioN/A Current Ratio0.81 Quick Ratio0.72 Sales & Book Value Annual Sales$53.47 million Price / Sales0.77 Cash FlowN/A Price / Cash FlowN/A Book Value($1.48) per share Price / Book-0.58Miscellaneous Outstanding Shares47,950,000Free Float38,358,000Market Cap$41.22 million OptionableOptionable Beta-0.30 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Shantanu K. Gaur M.D. (Age 37)Co-Founder, CEO, President & Director Comp: $383.86kDr. Samuel G. Levy (Age 41)Co-Founder Mr. Christopher Geberth (Age 53)CFO & Treasurer Comp: $408.95kDr. Ram Chuttani M.D. (Age 64)MD, Chief Medical Officer & Founding Partner Mr. Brendan Michael Gibbons (Age 48)Chief Legal Officer & Corporate Secretary Matt WrightVice President of PeopleMs. Joyce JohnsonSenior Vice President of RA & QAMore ExecutivesKey CompetitorsTriSalus Life SciencesNASDAQ:TLSIAlpha Tau MedicalNASDAQ:DRTSElectromedNYSE:ELMDFONARNASDAQ:FONRVivani MedicalNASDAQ:VANIView All CompetitorsInstitutional OwnershipAccredited Investors Inc.Bought 12,500 shares on 7/20/2024Ownership: 0.104%View All Institutional Transactions ALUR Stock Analysis - Frequently Asked Questions How have ALUR shares performed this year? Allurion Technologies' stock was trading at $3.74 at the beginning of 2024. Since then, ALUR stock has decreased by 77.0% and is now trading at $0.8596. View the best growth stocks for 2024 here. How were Allurion Technologies' earnings last quarter? Allurion Technologies Inc. (NYSE:ALUR) issued its quarterly earnings data on Tuesday, May, 14th. The company reported $0.11 earnings per share for the quarter. The company had revenue of $9.39 million for the quarter. Who are Allurion Technologies' major shareholders? Allurion Technologies' top institutional investors include Accredited Investors Inc. (0.10%) and Concourse Financial Group Securities Inc.. How do I buy shares of Allurion Technologies? Shares of ALUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:ALUR) was last updated on 7/28/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allurion Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allurion Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
